Medical AI startup Aesop Technology secures $3M to further expand in the US

Taiwanese medical AI startup Aesop Technology has raised $2.9 million in a fundraising spherical led by Taiwania Capital forward of its Series A funding occasion. The spherical additionally drew the participation of Colopl Next, 500 Startups, and BE Capital.

A spin-off from Taipei Medical University, the firm was established in the US in 2020 and is now at the moment headquartered in San Francisco. It gives two AI-powered options: RxPrime, a drugs determination assist software, and a medical documentation enchancment software for recognizing incorrect diagnoses referred to as DxPrime, which was launched in June this yr.

WHAT IT’S FOR

Aesop says it is going to use its contemporary funds to strengthen its know-how group and further expand its presence in the US market. 

THE LARGER TREND

The fundraiser comes after it launched each of its options on apps marketplaces Epic App Orchard and Olive Library over the previous few months. 

Last yr, it printed a paper with Harvard University which demonstrated the worldwide transferability of its AI mannequin for detecting remedy errors in EHR programs in the US.